An Open-Label Study to Assess Safety

Conditions

• Plaque Psoriasis

Interventions

• DRUG: Topical TA-102 A
• DRUG: Topical TA-102 B
• DRUG: Topical TA-102 C
• DRUG: Topical TA-102 D
• DRUG: Topical TA-102 E

Sponsor

Sun Pharmaceutical Industries, Inc.